AAPLOG

A victory for our patients. Over the past two decades, the FDA has repeatedly removed necessary safeguards on the chemical abortion drugs mifepristone and misoprostol. These deregulations have placed women and girls at greater risk of life-threatening complications, as well as coerced abortion by abusers and traffickers. Today’s ruling by the Fifth Circuit Court of Appeals

The baseless narrative that the U.S.’s poor maternal health is attributable to abortion regulations only serves to harm women.  Several weeks ago, we responded to these claims by abortion advocates on social media, refuting them and calling attention to the factors that actually contribute to the maternal mortality crisis in this country. Yet this narrative attempting to connect the 2021 surge in

Life-affirming medical professionals share the objective of promoting optimal healthcare for both pregnant women and preborn children. To achieve this goal, it is essential that we use precise, medically accurate language to describe the pregnancy-related practices which intentionally harm our patients. It is especially necessary to distinguish these practices from medical interventions that separate a

Ohio’s proposed constitutional amendment on abortion should concern both medical professionals who care about the health of their patients as well as citizens concerned about their healthcare.   Patients in Ohio can already receive the excellent care they need under current state laws. Under current state law, physicians can provide care for women with life-threatening pregnancy

AAPLOG’s Board of Directors invites ACOG CEO to a scholarly debate with our CEO at Duke University on whether induced abortion is consistent with good medicine.   AAPLOG believes that scientific progress and advancement depend on the free exchange of ideas.  Read full letter here. Also, read reporting on the invitation by the Washington Post here

Description:  By illegally approving chemical abortion drugs, the U.S. Food and Drug Administration failed to abide by its legal obligations to protect the health, safety, and welfare of girls and women. The FDA never studied the safety of the drugs under the labeled conditions of use, ignored the potential impacts of the hormone-blocking regimen on

Today is a victory for our patients. Since the drugs Mifepristone and Misoprostol were approved for use in chemical abortions in 2000, the FDA has repeatedly removed necessary safeguards meant to decrease the risk of serious harm to the women who consume them. Today’s 5th Circuit Court of Appeals order reinstating these safeguards for Mifepristone

Today’s ruling in the US District Court for the Northern District of Texas is a victory for all our patients. The FDA began a pattern of prioritizing the interests of the abortion industry over the health and safety of our nation’s women and girls 23 years ago by illegally and recklessly approving dangerous drugs for

Our hearts go out to all the women and their families who filed a lawsuit (Zurawski v. State of Texas) asking for clarity for patients and physicians from the state of Texas on their abortion law. As physicians who care for women and their children every day in our medical practices, we recognize the heartbreak